Andreas Moser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreas Moser has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alexander Luborzewski
Neurochemical Research Group, Department of Neurology, Medical University of Lübeck, Lübeck, Germany
1 shared publicationDoris Feineis
Institute of Organic Chemistry, University of Würzburg, Würzburg, Germany
1 shared publication- Franz Riederer
Department of Neurology, Inselspital, Bern University Hospital University of Bern Bern Switzerland
1 shared publication - Gerhard Bringmann
Institute of Organic Chemistry, University of Würzburg, Würzburg, Germany
1 shared publication - Joachim Scholz
Neurochemistry Research Group, Department of Neurology, Medical University of Lübeck, Lübeck, Germany
1 shared publication - Ralf God
Hamburg University of Technology
1 shared publication
Latest Publications
- 7 May 2002
- Published by Wiley in Journal of Neurochemistry
- Vol. 81 (4) , 814-819
Modification of tyrosine hydroxylase activity by chloral derived β‐carbolines in vitro
β-Carbolines have been suggested to be involved in the pathogenesis of Parkinson's disease as a result of their structural similarity to the neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The chloral-derived β-carboline derivative 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) causes cell loss in neuronal and glial cell cultures and induces a slowly developing neurodegenerative process in rats. In our experiments, effects of TaClo and its derivatives 2-methyl-TaClo (2-Me-TaClo), and 1-dichloromethylene-1,2,3,4-tetrahydro-β-carboline (1-CCl2-THβC) on tyrosine hydroxylase (TH) activity were investigated in TH assays using homogenate preparations of the rat nucleus accumbens and recombinant human TH (hTH1). TH activity was determined in vitro by measuring l-DOPA production with HPLC-ECD. Using homogenate preparations, TaClo, 2-Me-TaClo, and 1-CCl2-THβC inhibited TH in concentrations of 0.1 mm, while 1-CCl2-THβC in low concentrations enhanced TH activity. When TH was activated by PACAP-27, TaClo, 2-Me-TaClo, or 1-CCl2-THβC also inhibited activated enzyme activity in high concentrations. However, in the case of 2-Me-TaClo and 1-CCl2-THβC a biphasic effect was observed with a marked increase of TH activity in the nanomolar range. In our experiments using recombinant hTH1, TaClo, 2-Me-TaClo, or 1-CCl2-THβC did not modify enzyme activity. After activation of hTH1 by PKA all the tetrahydro-β-carbolines investigated in this study decreased l-DOPA formation. We suggest that these β-carbolines modulate dopamine synthesis by interacting with a protein kinase TH-activating system.
- 7 May 2002
- Published by Wiley in Journal of Neurochemistry
- Vol. 81 (4) , 814-819
Modification of tyrosine hydroxylase activity by chloral derived β‐carbolines in vitro
β-Carbolines have been suggested to be involved in the pathogenesis of Parkinson's disease as a result of their structural similarity to the neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The chloral-derived β-carboline derivative 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) causes cell loss in neuronal and glial cell cultures and induces a slowly developing neurodegenerative process in rats. In our experiments, effects of TaClo and its derivatives 2-methyl-TaClo (2-Me-TaClo), and 1-dichloromethylene-1,2,3,4-tetrahydro-β-carboline (1-CCl2-THβC) on tyrosine hydroxylase (TH) activity were investigated in TH assays using homogenate preparations of the rat nucleus accumbens and recombinant human TH (hTH1). TH activity was determined in vitro by measuring l-DOPA production with HPLC-ECD. Using homogenate preparations, TaClo, 2-Me-TaClo, and 1-CCl2-THβC inhibited TH in concentrations of 0.1 mm, while 1-CCl2-THβC in low concentrations enhanced TH activity. When TH was activated by PACAP-27, TaClo, 2-Me-TaClo, or 1-CCl2-THβC also inhibited activated enzyme activity in high concentrations. However, in the case of 2-Me-TaClo and 1-CCl2-THβC a biphasic effect was observed with a marked increase of TH activity in the nanomolar range. In our experiments using recombinant hTH1, TaClo, 2-Me-TaClo, or 1-CCl2-THβC did not modify enzyme activity. After activation of hTH1 by PKA all the tetrahydro-β-carbolines investigated in this study decreased l-DOPA formation. We suggest that these β-carbolines modulate dopamine synthesis by interacting with a protein kinase TH-activating system.